Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inherited thrombophilia.

Isobel D Walker1

  • 1Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK. isobel.walker@northglasgow.scot.nhs.uk

Vascular Medicine (London, England)
|January 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of Factor VIII Extended Half-Life Product Measurements in External Quality Assessment Programmes.

International journal of laboratory hematology·2026
Same author

Cold Stored Platelets: A Solution for Platelet Aggregation External Quality Assessment/Proficiency Testing.

International journal of laboratory hematology·2025
Same author

Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers-for the External Quality Assurance in Thrombosis and Haemostasis Group.

Seminars in thrombosis and hemostasis·2024
Same author

Internal Quality Control in Hemostasis Assays.

Seminars in thrombosis and hemostasis·2023
Same author

Laboratory international normalized ratios determined with commercial thromboplastins in >450 centers before and after the establishment of the International Standard for human thromboplastin-rTF 16: data from United Kingdom National External Quality Assessment Scheme for Blood Coagulation.

Journal of thrombosis and haemostasis : JTH·2023
Same author

Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide.

Journal of thrombosis and haemostasis : JTH·2022
Same journal

Predictors and clinical course of chronic limb-threatening ischemia with hemodynamic failure after endovascular therapy.

Vascular medicine (London, England)·2026
Same journal

Bigger isn't always scarier: Aneurysm size and illness perception in thoracic aortic aneurysm patients undergoing surveillance.

Vascular medicine (London, England)·2026
Same journal

Initiation of an emergency department discharge pathway for low-risk patients with venous thromboembolism: Factors impact real-world practice.

Vascular medicine (London, England)·2026
Same journal

'It works in practice, but does it work in theory?' An important addition to the body of real-world evidence supporting carotid endarterectomy.

Vascular medicine (London, England)·2026
Same journal

Carotid endarterectomy and stenting in France: A 10-year nationwide evaluation of practice and outcomes.

Vascular medicine (London, England)·2026
Same journal

Images in Vascular Medicine: When coronary anatomy goes the wrong way-A diagnostic challenge.

Vascular medicine (London, England)·2026
See all related articles

Certain inherited clotting disorders, like Factor V Leiden, may increase peripheral vascular disease risk. However, evidence linking other thrombophilias to arterial disease or anticoagulant effectiveness in graft surgery remains limited.

Area of Science:

  • Vascular Medicine
  • Hematology
  • Genetics

Background:

  • Heritable thrombophilias are genetic conditions affecting blood clotting.
  • Peripheral vascular disease (PVD) encompasses conditions affecting circulation outside the heart and brain.
  • A potential link between thrombophilias and PVD exists but requires further elucidation.

Purpose of the Study:

  • To investigate the association between heritable thrombophilias and peripheral vascular disease.
  • To examine the role of specific thrombophilias, such as Factor V Leiden, in arterial occlusive disease.
  • To assess the impact of thrombophilia on vascular reconstruction outcomes and anticoagulant therapy.

Main Methods:

  • Literature review and synthesis of existing evidence.
  • Analysis of prevalence data for specific thrombophilias in PVD patients.

Related Experiment Videos

  • Evaluation of studies on vascular reconstruction failure and anticoagulant use.

    • Main Results:

    • Limited evidence suggests a possible association between certain thrombophilias (e.g., activated protein C resistance, FV Leiden) and peripheral arterial disease.
    • No clear evidence links other heritable thrombophilias to arterial occlusive disease.
    • FV Leiden may be linked to vascular reconstruction failure, but evidence on anticoagulant efficacy is lacking.

    Conclusions:

    • Specific heritable thrombophilias might elevate PVD risk, particularly FV Leiden.
    • Further research is needed to clarify the role of thrombophilias in arterial disease and optimize surgical interventions.
    • The effectiveness of anticoagulants in managing graft surgery outcomes for thrombophilia patients is currently unsubstantiated.